The Real-World Data of Treatment with Abemaciclib for HR-positive HER2-negative Metastatic Breast Cancer: A Multicentral Cohort Study
Not Applicable
- Conditions
- HR-positive HER2-negative Metastatic Breast Cancer
- Registration Number
- JPRN-UMIN000043149
- Lead Sponsor
- Aichi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Participation in a clinical trial any time after the initiation of abemaciclib treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method